Astract. The present study examined the role of cell-mediated immunity (CMI) 
Introduction
Glomerulonephritis has classically been defined as an inflammatory process involving the glomerulus, one usually mediated by the deposition of immune complexes or anti-glomerular basement membrane (GBM)' antibodies (1, 2) . Although sensitization of the cellular immune system at immunization was assumed in the past, no pathogenetic role was ascribed to cellmediated immunity (CMI) (3) . Increasing evidence, however, indicates an important role for CMI in the pathogenesis ofmany human and experimental animal types of nephritis. The macrophage appears to play a critical part in the proliferation and GBM damage in certain forms of nephritis (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) ; lymphocytes may participate in yet other mechanisms of immunologic damage (17, 18) ; and CMI of uncertain type may be important in still other forms of nephritis (19) (20) (21) (22) (23) (24) (25) (26) (27) .
The experimental models implicating CMI in the pathogenesis of nephritis have relied upon a humoral mechanism to plant immunoglobulins in the glomerulus with consequent recruitment ofexogenous cells, stimulation ofendogenous resident cells, and development of nephritis. Conclusions regarding the role of monocytes, macrophages, and lymphocytes have been based upon studies that focused upon migration patterns and identification of various types of cells in tissue sections, and upon effects of specific antisera to certain cell subpopulations.
Nonetheless, these various investigations have been performed within the milieu of an intact humoral immune system. This factor complicates evaluation of the isolated role of CMI in the development of glomerulonephritis in the absence of glomerular immunoglobulin deposition. Indeed, there are no immunological models ofglomerulonephritis induced without the participation of immunoglobulin deposits.
We have recently shown that functional T cells are required for the development of anti-GBM nephropathy in a murine model (28, 29) , and more recently demonstrated that a proliferative anti-GBM nephritis could be induced in chickens (30) . Our development ofthis latter model has allowed us to separate the effects of the humoral immune system from CMI to further study the development of the glomerulonephritis in chickens. The results show that glomerulonephritis develops in animals with normal intact CMI, with partly impaired, and apparently absent humoral immunity to GBM. These findings suggest that the nephritis in this model may be mediated by CMI in the absence of humoral immunity or by other mechanisms that have not been elucidated. This dissociation of the development of nephritis from the humoral immune system implicates a previously undescribed process or processes in the pathogenesis of experimental glomerulonephritis in this model.
Methods

Phase I
Chickens. 100 neonatal J. J. Warren chicks 2-20-h-old were obtained from the hatchery and placed in an incubator in a laminar flow room. These animals were used in the first phase of studies that examined induction of nephritis in normal and humorally deficient birds. Animals were handled with gloves and masks, received autoclaved food, and autoclaved, acid-treated water (0.6 ml of 12 N HCl per gallon). The utmost care was always taken not to expose animals to environmental viral or bacterial infections. All utensils and cages were steam cleaned weekly and the same Vivarium technician assumed the care of the animals throughout the study.
Bursectomy (Bsx). 75 chicks received 2 mg cyclophosphamide in 0.1 ml volume ofsterile water in the thigh muscle within 20 h ofhatching (31) (32) (33) . This dose was repeated daily for 4 d total. The 25 cohorts did not receive cyclophosphamide and served as controls.
Immunoglobulin levels. At 5 wk of age, all chickens were bled from the wing veins and serial dilutions of sera were examined by double diffusion in micro-Ouchterlony plates using monospecific rabbit antichicken IgG (Miles Laboratories Inc., Elkhart, IN). Plates were examined at 24 and 48 h, washed, dried, and stained with Coomassie Blue. Titers are expressed as the reciprocal of the dilutions. Selected sera from Bsx birds were also examined by immunoelectrophoresis in 1% agarose, pH 8.6 , for 90 min with rabbit anti-whole chicken serum to assess levels of IgM.
Immunization with sheep red blood cells (SRBC) . To evaluate the ability of the chickens to respond to an antigenic stimulus, animals were immunized with SRBC (34) . These were prepared by collecting SRBC in Alsevers solution, washing them three times in sterile phosphatebuffered saline (PBS), pH 7.4, at 4VC, and resuspending them in sterile PBS to a total cell volume of 20%. Three sets of birds were immunized intraperitoneally with 0.5 ml of 20% SRBC twice at l-wk intervals. The three groups were normal controls, Bsx chickens with IgG titers < 1:16, and Bsx chickens with IgG titers > 1:32. Animals were bled I wk after each injection and the sera examined for anti-SRBC antibody by hemagglutination. All sera were absorbed five times with washed SRBC (1:10 vol) at 4VC to absorb naturally occurring hemolysin, heat inactivated at 560C for 30 min, and divided into two portions. One portion was incubated with a vol/vol of 0.2 M 2-mercaptoethanol at 370C for 30 min to inactivate IgM, and the other was used only after decomplementing. Serial dilutions of each were made in microtiter plates using 2.5% vol/vol SRBC in PBS, pH 7.4. Cells and test sera were incubated at 230C for 2 h and agglutination determined.
Preparation of bovine GBM. Normal and Bsx chickens selected as low responders to SRBC with low IgG levels were immunized with bovine GBM. Beef kidneys were obtained from a local abattoir and frozen at -50'C until use. They were then thawed at 4VC in PBS and the cortices separated from the medullae. Minced cortices were pressed through sieves, 40, 80, and 140 mesh, respectively, to collect whole glomeruli on a 200-mesh sieve (28, 29, 35) . Extensive washing in PBS, 4VC, was carried out at each step. Glomerular preparations were examined by phase-contrast microscopy to ascertain degree of tubular contamination. Preparations used to immunize animals were 95% pure glomeruli. The glomeruli were washed in deionized water, Iyophilized, and stored.
Immunization with GBM. Chickens were immunized with Iyophilized bovine glomeruli, 10 mg dry wt/bird, resuspended in sterile PBS at 4°C, emulsified in complete Freund's adjuvant H37Ra (CFA) (Difco Laboratories, Inc., Detroit, MI), 1:1 vol/vol, and given in a 1-ml final volume subcutaneously in the axilla. Immunizations were begun at 9 wk of age and continued every other week until termination of the experiment. Both normal and Bsx chickens were immunized with GBM.
Control immunizations. Bsx and normal chickens were injected using the same schedule and method as birds receiving GBM. However, control birds received PBS in CFA without any GBM.
Tissue. Animals from the four study groups were serially killed at 5, 7, 9, 11, 13, 15, 17 , and 19 wk after the beginning of immunizations.
At the time of sacrifice the bursa or bursal remnant was dissected free, weighed, and fixed in 10% buffered formalin. Kidney tissue was divided into three portions. One part was fixed in 10% buffered formalin for light microscopy, the second snap-frozen in dry ice isopentane for immunofluorescence, and the third fixed in formol-sucrose/gum-sucrose for nonspecific esterase staining (36) (37) (38) . Animals were sacrificed by exsanguination with ether and/or ketamine anesthesia. Pathology a) Light microscopy. Formalin-fixed tissue was paraffin embedded and serial sections 3 ,um in thickness was stained with periodic acid Schiffs reagent (PAS) and hematoxylin eosin (H&E) (36) . Bursal tissue was examined for normal morphology, lymphoid tissue, follicles, and germinal centers. Kidneys were assessed qualitatively without knowledge of the study group for degree of proliferation, tubular atrophy, crescent formation, and interstitial infiltrate. Glomerular grading was on a 0-4+ basis, with notation of focal or diffuse proliferation. Proliferation was quantitatively assessed using a Zeiss eye-piece micrometer and by measuring the diameter of glomerular tufts in 10-20 glomeruli cut through the stalk (30 (38, 40) . Deparaffinized sections were washed in deionized water, air dried, and incubated in pararosanilin/alpha-naphthyl acetate/sodium nitrite, pH 6.0, mixed immediately before incubation. Washed sections were counterstained with 1% methyl green, washed, mounted, and examined for esterase-positive cells in the glomeruli and crescents. Staining of proximal tubular cytoplasm and intravascular monocytes served as an internal control.
Anti-GBM assay. Sera obtained at sacrifice were evaluated for anti-GBM antibodies. Two types of assays were used to assess circulating antibody response to bovine and chicken GBM. In the first, serial dilutions of chicken serum were examined by indirect immunofluorescence using fluoresceinated anti-chicken IgG and normal bovine and chicken kidneys (28) . The second assay system was used to provide quantitative information about the degree of immune responsiveness to the bovine GBM. Collagenase-solubilized GBM was prepared by mixing lyophilized bovine glomeruli (100 mg) in Tris HCl buffer, pH 7.4, with 0.01 M CaC12 and 6.4 mg collagenase (Sigma Chemical Co., St. Louis, MO) at 37°C for 22 h, and by dialyzing the supernatant against deionized water (23) .
The solubilized GBM (10 mg) was attached to SRBC via CrC13 (5 ml) for 30 min at 23°C, was washed, serial dilutions of sera were absorbed with SRBC and heat inactivated as described above, and then were mixed with a 1% suspension of coated cells in microtiter plates. Hemagglutination titers are expressed as the reciprocal.
Wattle thickness assayfor CMI. The wattle is the fleshy appendage hanging down from the throat or chin ofthe chicken. The Mycobacterium tuberculosis H37Ra used to immunize the animals contains antigens in common with clinically used purified protein derivative [PPD] diffusion in micro-Ouchterlony plates using anti-chicken IgG, IgA, and IgM. Specific activity was determined in duplicate from eluted labeled IgG using a single tube from the apex of the IgG peak which, after concentration, showed no other detectable proteins, and demonstrated a single line in double diffusion and immunoelectrophoresis against antichicken whole serum and anti-chicken IgG. The specific activity was 9.5 X 106 cpm/mg of IgG. The presence of antibody to GBM was sought in column fractions by indirect immunofluorescence and verified to be present only in the IgG peak from the animals with in vivo deposits of chicken IgG. Kidneys of Bsx-GBM immunized chickens that had no detectable IgG present along the GBM by immunofluorescence were similarly pooled and eluted. The eluate was prepared in a fashion identical to that from GBM antibody-positive chickens, except it was not radiolabeled, but eluted and concentrated.
b) Calculations ofkidney-fixing antibody (KFAb). Various quantities of chicken IgG anti-GBM antibody radiolabeled with I125 were injected intravenously into normal chickens. The animals were exsanguinated 2 h after injection. Samples of whole blood were counted and both kidneys were harvested, weighed, homogenized in a Waring blender (Waring Products Div.), and repeatedly washed in cold PBS until the supernatant contained minimal amounts of 1125 and was clear. The entire washed homogenate from each pair of kidneys was counted in 1 ml vol in a Beckman Gamma-8000 scintillation counter (Beckman Instruments, Inc., Fullerton, CA) with a 3-in. iodide crystal. Radioactivity was corrected for decay of 1125 and background counts. Normal chicken IgG obtained from Cappel Laboratories Inc. was similarly chromatographed, labeled with 1125 as described, and the specific activity adjusted to be the same as the injected anti-GBM antibody. Normal chickens received various quantities of the radiolabeled normal chicken IgG and the blood and kidneys were counted as described above. The amount of KFAb was determined from the cpm bound to kidney, and corrected for nonspecific binding using the specific activity of the IgG injected. c) Determination oflimits ofdetection ofchicken IgG. Chicken IgG fractions of known KFAb concentration as determined above were injected into six chickens in six different doses. Animals were killed 1 h later and cryostat sections of kidneys were cut in triplicate and intermingled with each other, as well as with sections from normal and immunized chickens with in vivo GBM deposits of IgG of various intensity. Two sections were mounted on each slide and all were coded so that Dr. Bolton, of this institution, did not know whether the biopsy was from a normal chicken, a GBM recipient chicken kidney biopsy, or from an eluate recipient chicken. The intensity of fluorescence was then independently evaluated using the immunofluorescence grading scale previously detailed. This procedure was repeated on two separate additional days, again with intermingling of all the sections and reading in blind. The mean fluorescence intensity for each amount of KFAb injected was plotted on semilogarithmic paper to ascertain the limits of ability to detect GBM fixation of chicken IgG in vivo. three dose levels, to produce a spectrum of in vivo GBM deposits of IgG. Chicken kidneys were biopsied at 14 and 30 d, and animals sacrificed at 6 wk. Sections were evaluated by light and immunofluorescence microscopy. The sections read by immunofluorescence were coded in the fashion described above for determination oflimits ofdetection ofchicken IgG and read in blind with sections included from normal animals, nephritic GBM birds containing antibody on the basement membrane, and sections of specimens used in "c" above for determination of IgG deposits. Light microscopic sections were also read blindly for evidence of nephritis. and high responders were twice immunized with SRBC as described in the first part of the study. Birds were selected for immunization with GBM, which was first performed at 12 wk of age. There were 26 Bsx-GBM animals, 27 Bsx-CFA, 17 control-GBM, and 18 control-CFA birds in this portion of the study. 6 wk after immunization, selected animals from each group were examined for circulating anti-GBM antibody by the indirect method. Animals used for transfer studies were exsanguinated, and suspensions were prepared from spleens by mincing and pressing sequentially through a 60-, 100-, 325-, and 400-gauge sieve, and then by passing suspensions through 23-and 25-gauge needles, followed by washing twice with RPMI 1640. Spleen was selected because in vitro blast transformation studies of peripheral lymphocytes, spleen cells, and lymph node cells suggested that the best response was present in spleen cells (unpublished observation). Cell viability was assessed by trypan blue exclusion and was >70%. Normal unmanipulated 6-wk-old chickens received intravenous cells in a concentration from 4 X 107 to 1 X 109 per injection. Biopsies were taken from one kidney at 0, 15, and 30 min, and 4 h after infusion of cells, and at 24 h from the opposite kidney. The presence of any antibody along the GBM in immunized donor chickens was ascertained by immunofluorescence at the time of harvesting of cells. Recipient animals were killed 3 and 7 d later with light microscopic examination of kidney tissue.
2) Autoradiography. Other chickens received cells with three injections of tritiated thymidine (1 uCi/g body wt), 6.7 Ci/mmol sp act (New England Nuclear). chickens were alive at 5 wk (93%) compared with 25 of 25 control birds. During the course of the study, four additional Bsx animals died of inapparent causes, while there were no deaths in the control animals. Thus, overall survival in Bsx birds was 88% compared with 100% for normal animals. No difficulties were encountered with infections, poor oral intake, or malnutrition in any of the birds. However, to ascertain any effect Bsx might have on body weight, another group of 60 chickens of the same four study groups was weighed at the 26th wk of age (Table I) . In these animals, body weight was less in male birds than in females in each study group, and male adjuvant birds were heavier than male Bsx-adjuvant birds. There were no differences between GBM-immunized birds of the same sex, whether normal or Bsx. b) Bsx. Bursal tissue or remnants were weighed and examined histologically in chickens at the time of sacrifice. 13 wk after immunization (22 wk of age) and later, little or no bursal tissue was present in any birds. Therefore, the first 13 wk after immunization were used to compare Bsx and normal chickens' bursae. In Bsx birds, only remnant lymphoid follicles and disorganized architecture were found (Fig. 1) . These findings varied in severity, but generally there was severe depletion of lymphoid cells compared with normal chickens. Bursal weights in the Bsx chickens were significantly less than normal controls, P < 0.0025 (Table II) . The same type of depletion and decreased bursal weights were observed at each sacrifice period, week 5-13. c) Immunoglobulin levels. Serial titers of chicken IgG ranged from 32 256. 18% of Bsx animals had titers 64-256, 25% a titer of 32, and the remaining 56% had titers of <16. The mean titers in birds selected for immunization was 14.2±1.6, n = 43 (Table  II) . This was significantly less than control birds, P < 0.0001. Immunoelectrophoresis of sera from normal birds revealed strong IgG lines. Bsx birds with low titers of IgG had absence of the IgG line or only a trace remnant as measured by electrophoresis. IgM was present in all animals.
d) SRBC immunizations. We assessed the ability of Bsx and normal birds to mount a humoral immune response using SRBC. Bsx birds with low, medium, and normal IgG levels (titers < 16, 32-64, and >128) were selected to receive SRBC as described in Methods. Four each ofnormal and medium responders, and 11 low responder birds were injected (Table II) . Titers in normal chickens were 162±59, which decreased to 33±12 using 0.2 M mercaptoethanol-treated serum. Titers in medium responders were 68±63 for normal serum and 9±7 in IgMinactivated serum. Two Bsx medium-IgG-level birds did not develop any antibody response. None of the low responder Bsx birds had any agglutinating activity against SRBC at 2 wk in either normal or mercaptoethanol-treated serum. Thus, Bsx chickens with low titer IgG as measured by immunodiffusion also failed to mount a humoral response to stimulation with the complex antigen SRBC. e) Wattle thickness increments. The wattle thickness in all birds before injection of intracutaneous PPD was 2-3 mm in 48 birds. The thickness at 48 h after PPD ranged up to 11 mm. The mean increment of Bsx-GBM birds was 3.89±0.45 mm, compared with 3.37±0.75 mm in control-GBM chickens, which was not significantly different (Table II ). An increase in wattle thickness developed in 93% of Bsx-GBM animals and 73% of control-GBM, P = NS. 12 normal nonimmunized chickens had no detectable wattle thickness increment to PPD 48 h after skin tests were placed. 
n is given in parentheses.
* 68% totally negative by hemagglutination.
P < 0.005. § 64% totally negative. 11 P < 0.001. ¶ Limits of detection by fluorescence, <6 fg chicken IgG/glomerular section. ** Glomerular size: Bsx vs. Bsx-GBM, P < 0.001; control vs. GBM, P < 0.05; Bsx vs. control, P = NS; control vs. Bsx-GBM, P < 0.005; Bsx vs. GBM, P < 0.05; GBM vs. Bsx-GBM, P = NS.
Development of experimental glomerulonephritis a) Anti-GBM antibody levels. All of the control-GBM birds developed circulating anti-GBM antibodies. Titers ranged from 256 to >4,096 with a mean of >2,1 18±532 (Table III) . Only 12 of 37 (32%) Bsx-GBM birds tested developed circulating anti-GBM antibody, which ranged from 2 to 512 (mean < 312±95, P < 0.005). The mean of the anti-GBM antibody for all Bsx-GBM birds combined was 99±38, P < 0.001. Birds that had circulating anti-GBM antibody against bovine kidney sections were also positive against chicken kidney sections, but this was not quantitated. Positive sera were positive both by indirect immunofluorescence and hemagglutination assay. b) Immunofluorescence findings on kidney tissue. At 5 wk after immunization, normal chickens had developed linear deposits of IgG along the GBM as previously described (30) . During the ensuing weeks the intensity of deposits increased from 1+ to 3-4+ in all control birds. In contradistinction, GBM deposits were seldom observed in Bsx birds. 64% of Bsx chickens had no detectable IgG along the GBM. In the other 36% of animals, the intensity of linear staining was <1.0+ in half. Thus, 82% of animals developed 0-1+ IgG deposits. Using the 11-point 0-4+ scale (38) , the intensity of linear staining for IgG on the GBM in normal controls was 2.19±0.32 compared with 0.53±0.16 for Bsx-GBM, P < 0.005 (Table III) . There were no deposits of C-3, other immunoglobulins, fibrinogen, or albumin in the animals. The Bsx-control and normal controls did not develop any deposits. c) Histopathology. Both Bsx-GBM and control-GBM chickens developed a proliferative glomerulonephritis associated with a marked increase in the mesangium, narrowing ofcapillary lumina, and diminution ofBowman's space (Fig.  2) . Epithelial crescents were present in 24% of Bsx-GBM animals and 38% ofcontrol-GBM birds (P = NS). The degree ofcrescent formation ranged from 2.1 to 23.5% in Bsx-GBM birds (14.3±3.8%), and from 2.3 to 25.0% in control-GBM animals (15.2±2.3%), P = NS. Analysis of glomerular size (Table III) demonstrated that Bsx-GBM and control-GBM glomerular proliferation was similar, and both were significantly greater than either Bsx-control or normal-control chickens. There was no correlation between GBM deposits of IgG in Bsx chickens and proliferation, with birds having no detectable deposits developing equal degrees ofglomerular proliferation and crescents.
The histologic changes in control and GBM-immunized animals are analyzed in a different fashion in Fig. 3 . Sections were reread without knowledge of the previous qualitative or morphometric analysis or immunization status of the animal and assessed in terms of the percentage of glomeruli in a given section with proliferation from 0-4+ and with crescents. 16-89 glomeruli were present per section (37.8±1.6). A histologic index was then calculated by multiplying the percentage of glomeruli with a particular histologic grade by the grade, divided by 100. Thus, the lowest score would be 0 and the highest possible score would be 4. The histologic index is plotted against weeks after immunization and age in Fig. 3 .
In the 5th wk after immunization, the killed GBM re- cipient animals had histologic indices of 0.4. By the 7th wk, the histologic index was a maximum of 0.82. There was a gradual increase in the histologic index for the ensuing weeks, with animals in the 9th wk having a range of histologic indices to a high of 2.14. This trend continued throughout the remainder ofthe study with a shift ofthe histologic index to the right as a function of time. There was always a wide scatter of points, with some animals in each time period having minimal changes. The presence of crescents in each of the sections is also shown in Fig. 3 , and was likewise associated with increase in length of time of immunization. The correlation coefficient for crescents relative to time after immunization in control-GBM animals was r = 0.73, and for Bsx-GBM recipient animals was r = 0.81. Fig. 3 illustrates that the histologic changes were somewhat more severe in Bsx-GBM than in control-GBM animals, since the symbols for Bsx-GBM recipient animals lie further to the right in each time period after immunization except for the 15th wk. Of 15 normal or CFA recipient animals and 24 Bsx-CFA or Bsx animals, some were followed to nearly 40 wk of age, >10 wk longer than GBM recipient animals, to be certain that spontaneous aging changes did not account for the histologic lesions. Most of these animals had histologic scores of0.6 or less, regardless ofage, with only a few animals having scores greater than that, but all animals were <1.0. Furthermore, none of these animals had any crescents and they were all histologically distinct from animals immunized with GBM. 1 of 39 Bsx-CFA, CFA, and control animals had a histologic index of >0.8, compared with 19 of 37 Bsx-GBM and 7 of 13 control-GBM animals. 8 of 37 Bsx-GBM and 2 of 13 control-GBM animals had histologic indices of >2.0, and two animals, both in the Bsx-GBM group, had histologic indices >3.0. Crescents were seen as early as 7 wk after immunization in GBM recipient animals, even when the histologic index was low (0.4 and 0.6, in three animals), but were more frequently present when the histologic index was > 1.0. Crescents were present in half of all animals with histologic index > 1.0. If the upper limits of a normal index is taken as 0.8, as seems reasonable from Fig. 3 , and crescents are considered as one form of nephritis, then 20 of 37 Bsx-GBM and 9 of 13 control-GBM chickens had disease, compared with 1 of 39 control animals with probable spontaneous nephritis, P < 0.001. d) Chronological and associative interrelationships among anti-GBM titers, GBM deposits ofIgG, and histopathology. Tables IV-IX present data on the interrelationship between humoral antibody formation to GBM, in vivo deposits of IgG along the GBM, time, and histologic changes in glomeruli pre- Table IV , serum anti-GBM titers are compared with time after the first immunization. There was a trend toward a gradual increase in titer with time, with control-GBM animals in the 13-19th wk having, in many cases, titers The time course of development of IgG along the GBM is presented in Table V . Control-GBM immunized animals had deposits by the 5th wk, with a gradual tendency for the deposits to increase with time up to the 19th wk. However, there were animals with minimal deposits even in the 19th wk, and linear regression analysis of the time course relative to intensity of deposits was not significant. Bsx-GBM chickens usually developed no antibodies along the GBM, even by the 19th wk, and animals with 0-trace deposits comprised the majority of the group. A few animals had heavier deposits, but there was not an increasing number of animals or amount of deposits with time in Bsx chickens.
The relationship between anti-GBM titers and basement membrane deposits of IgG is presented in Table VI . There was a poor correlation between the titers and GBM deposits in the control-GBM animals, r = 0.49. 24 of the Bsx-GBM chickens had GBM deposits of 0-trace intensity and antibody titers of 0 to < 1:8. There was no correlation between circulating antibody levels and intensity of IgG on the GBM in those few birds that did have positive sera for antibody and deposits along the GBM.
Table VII presents the data on correlation between the histologic and immunofluorescence findings. Sections were graded qualitatively in terms of whether the lesions were focal or diffuse, -with an intensity grade from 0-4+. There was no correlation in control-GBM animals between the amount of IgG on the GBM and the associated histologic findings, with some animals having 3-4+ deposits of IgG and minimal light microscopic changes, while others had heavy deposits of IgG and severe histologic changes. Bsx-GBM recipient animals had a wide spectrum of histologic abnormalities, but the severity of histologic changes was not related to the amount of GBM deposits of IgG. Animals with 0-trace deposits had histologic changes as severe as 4+ diffuse proliferation with crescents. Seven of the nine Bsx-GBM animals with crescents had 0-trace deposits of IgG on the GBM.
Glomerular size is compared with GBM deposits in Table  VIII . Normal glomerular size is < 13 U. There was no correlation between intensity of GBM deposits of IgG and the size of the glomeruli in the control-GBM chickens, nor was there any correlation between size and deposits of Bsx animals. Similarly, there was no correlation between histologic abnormalities and serum anti-GBM titers in either the Bsx-GBM or control-GBM animals (Table IX) .
e) Characterization and quantitation ofGBM deposits. The KFAb of eluted nephritic kidneys was 0.8% of the total IgG eluted from the kidneys. The relationship between the ,ug of KFAb deposited per gram of wet weight in normal chickens and immunofluorescence staining intensity grade are presented in Fig. 4 . Slightly >2+ linear deposits of chicken IgG result from the deposition of <1 ug of KFAb/g of wet weight, and there was a linear relationship between the logarithm of the amount of KFAb bound and the immunofluorescence intensity. A small amount of KFAb resulted in trace amounts of staining that were similar to the intensity of GBM staining found in normal chickens. There was a very good correlation between the amount of KHAb per gram of wet weight in the injected 
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n of GBM-Bsx birds is given in parentheses, total n diffuse. * One GBM control bird.
t Two birds.
Total n = 13. § Three birds.
(1) kidneys and the immunofluorescence staining intensity, r = 0.96, P < 0.001. Note that the chickens used were all normal and thus had some background staining for IgG. In Bsx chickens there is essentially no IgG background and so the amount of detectable deposits of IgG would be considerably less than the 0.01 ,g/g wet wt. There were 1.42±0.04 million glomeruli in two kidneys, 710,000 glomeruli/kidney, or 164,352 glomeruli/ g of whole kidney. Since all of the IgG immunofluorescence was in glomeruli, the most accurate representation of immunofluorescence deposits of KFAb would be on the basis of IgG/ glomerulus. The average glomerulus is -40 micra thick and cryostat sections are four micra in thickness. Thus, there would be 10 sections/glomerulus and the amount of KFAb detected per glomerulus would be described by: KFAb/glomerulus = (KFAb ,ug/g wt)/(164,352 glomeruli/g X 10 glomerular-sections/glomerulus) = (KFAb) X (6.08 X l0-7) Ag/glomerularsection. Thus, using 4-micra thick sections, the amount of chicken IgG that was detected on GBM as shown in Fig. 4 (Fig. 5 A) . The staining was present in all chickens. Birds with proliferative nephritis de- veloped an increased number of these faintly esterase-positive cells (Fig. 5 B) , but there were never any glomerular infiltrates of cells with heavy dark granules characteristic of macrophages.
Esterase-positive cells were also not present within epithelial crescents or the interstitium. However, we did observe heavily esterase-positive cells within Bowman's space in close proximity to glomerular tufts and crescents (Fig. 5 C) 
Discussion
We have previously shown that functional T cells are required to develop anti-GBM disease in mice (28, 29) All previous models studying CMI in glomerulonephritis have used a planted antigen and relied on nephritis of "humoral" origin with recruitment of cellular components of the immune system (8, 12-15, 17, 18, 44, 45 There was similarly no correlation between circulating anti-GBM antibody or GBM deposits of IgG and the histologic lesion. Many birds with minimal or no deposits had lesions as severe or more so than those with antibody on the GBM. This lack of correlation was shown by several approaches, including quantitative measurements through coronal glomerular sections and examination of the distribution and severity of lesions in individual birds (Tables VII-IX) . Further, the abnormalities were clearly not related either to cyclophosphamide, CFA, or the aging process (Fig. 3) .
Development of nephritis, therefore, was a result of immunization with GBM. The ensuing nephritis could theoretically arise because of auto-antibody to GBM, a CMI response to GBM, humoral combined with CMI, or unexplained mechanisms. The amount of antibody bound to GBM in vivo in control-GBM birds was less than that which has been shown necessary to induce disease in mammals. Unanue and Dixon (46) showed that 150-200 ,ug (2.9 ,g/glomerulus) of heterologous KFAb in rats was required to induce disease, while Lerner The glomerulonephritis in Bsx-GBM and control-GBM birds was quite severe. Nonetheless, no decrease in glomerular filtering ability was observed. Maintenance of normal filtration may be related to the unique structural-functional association of the glomerular capillary loops and the mesangium. Avian glomeruli are much smaller and more oriented to a central mesangium. Even with massive enlargement ofthe mesangium, the capillary loops simply remain on the periphery, surrounding the mesangium without compromising luminal cross sectional space to a significant degree. In addition, chicken leukocytes are deficient in proteolytic enzymes capable of injuring basement membrane and allowing protein leakage (55) . Total serum protein levels were reduced in Bsx-GBM birds, probably related to the low IgG levels. The reason for the mild lowering of albumin is unclear, but may reflect some effect of cyclophosphamide on protein metabolism. Although we did not weigh the birds in phase I studies, similar groups of animals demonstrated weight differences only between males and females, suggesting that nutritional factors did not account for the differences in serum albumin.
In conclusion, we have immunized normal and Bsx chickens and produced anti-GBM nephritis in normal birds. Bsx chickens with documented severe depression of humoral immunity and intact CMI were unable to develop antibodies against the immunogen or their own GBM. Nonetheless, the Bsx chickens also developed a proliferative nephritis with crescents comparable to GBM-immunized controls. This nephritis developed in the absence of glomerular immunoglobulin, complement, or fibrinogen deposition, was not transferrable with nephritic eluates, but may potentially be transferrable by sensitized cells. Although CMI and humorally mediated immunity were not cleanly separated in all animals, the clear development of nephritis in those birds without apparent deposits strongly suggests, but does not prove, that CMI caused the lesion. These findings indicate that CMI may play a major role, albeit by unknown mechanisms, in the pathogenesis of this model of avian nephritis. By implication, CMI may be important in the pathogenesis of other kinds of nephritis as well.
